Prognostic Value of Cystatin C as a Predictor of Adverse Outcome in Severe Pneumonia Associated with COVID-19
Objective. To assess the cystatin C (CysC) prognostic value for probability of death in patients with severe and extremely severe pneumonia associated with COVID-19.Material and methods. A single-center prospective study included 72 patients with severe and extremely severe pneumonia associated with...
Saved in:
Main Authors: | D. I. Korabelnikov, M. O. Magomedaliev, S. E. Khoroshilov |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2023-06-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/2241 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Predictive Value of Cystatin C for AKI in Patients with COVID-19
by: M. O. Magomedaliev, et al.
Published: (2023-04-01) -
Cystatin C: diagnostic and prognostic value in acute kidney injury
by: D. I. Korabelnikov, et al.
Published: (2024-08-01) -
Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury
by: M. O. Magomedaliev, et al.
Published: (2024-11-01) -
Early Clinical and Laboratory Predictors of Hospital Mortality in Patients with Sepsis Secondary to Pneumonia
by: Yu. O. Rodionova, et al.
Published: (2024-04-01) -
Predictors of Death in Comorbid Patients with Thrombotic Complications: a Single-Center Retrospective Cross- Sectional Study
by: A. A. Ivannikov, et al.
Published: (2024-01-01)